The Leukaemia Foundation is proud to announce it has merged with Bloomhill Cancer Care, a highly regarded not-for-profit organisation based on the Sunshine Coast in Queensland, boosting the provision of cancer services to Australians living in regional areas.
A blood cancer drug 30 years in the making has been approved for use in Australia, giving hope to Australians with myelofibrosis, a rare form of blood cancer.
More infants, toddlers, children and teenagers are diagnosed with blood cancer than any other cancer in this country, with lengthy treatment regimes and debilitating side effects having a dire impact on those diagnosed
The Leukaemia Foundation is today calling for urgent action revealing blood cancer is set to become Australia’s most common and deadly cancer within a decade unless we act now.
The Leukaemia Foundation and Haematology Society of Australia and New Zealand (HSANZ) have again partnered to award three of Australia’s brightest blood cancer researchers and clinicians with PhD scholarships
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary new type of treatment that ‘trains’ a patient’s own immune cells to seek out and kill cancer.
Discover more about the latest developments in stem cell transplants.
In the ever-evolving landscape of blood cancer research, the quest to combat blood cancer continues to push boundaries. The New Directions in Leukaemia Research (NDLR) event in Adelaide last month brought together leading minds in the field to discuss breakthroughs, challenges, and the future of leukaemia treatment. From cutting-edge advancements in therapies to the promise of personalised medicine, the conference, sponsored by the Leukaemia Foundation, shed light on the latest discoveries and strategies shaping the fight against leukaemia.
With myeloma incidence rates set to more than double by 2035, the Leukaemia Foundation is urgently calling for greater awareness and equitable access to treatment across the country, so myeloma patients have the best chance of survival, no matter where they live.
